Immunity & Ageing,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Oct. 14, 2023
Abstract
Background
Increased
age
is
a
risk
factor
for
the
development
and
progression
of
retinal
diseases
including
age-related
macular
degeneration
(AMD).
Understanding
changes
that
occur
in
eye
due
to
aging
important
enhancing
our
understanding
AMD
pathogenesis
novel
therapies.
Microglia,
resident
brain
immune
cells
are
associated
with
both
maintaining
homeostasis
protection
neurons
loss
microglia
could
be
significant
player
related
neurodegeneration.
One
characteristic
migration
from
inner
outer
retina
where
they
reside
subretinal
space
(SRS)
contact
pigment
epithelial
(RPE)
cells.
The
role
aged
unknown.
Here,
we
depleted
C57/BL6
mice
fed
6
weeks
chow
containing
PLX5622,
small
molecule
inhibitor
colony-stimulating
factor-1
receptor
(Csf1r)
required
microglial
survival.
Results
P2RY12
+
displayed
highly
amoeboid
activated
morphology
were
filled
autofluorescence
droplets
reminiscent
lipofuscin.
TEM
indicates
actively
phagocytize
shed
photoreceptor
segments,
one
main
functions
pigmented
PLX5622
treatment
up
90%
was
visual
function.
Mice
on
depletion
diet
showed
reduced
contrast
sensitivity
significantly
lower
electroretinogram
c-wave,
measurement
RPE
functionality,
compared
age-matched
controls.
c-wave
coincided
increased
swelling
absence
microglia.
Conclusions
We
conclude
preserve
function
support
cell
function,
by
phagocytosing
segments
lipids,
therefore
compensating
known
decline
phagocytosis.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: April 5, 2024
Abstract
Background
It
is
well
established
that
traumatic
brain
injury
(TBI)
causes
acute
and
chronic
alterations
in
systemic
immune
function
changes
contribute
to
posttraumatic
neuroinflammation
neurodegeneration.
However,
how
TBI
affects
bone
marrow
(BM)
hematopoietic
stem/progenitor
cells
chronically
what
extent
such
may
negatively
impact
innate
immunity
neurological
has
not
been
examined.
Methods
To
further
understand
the
role
of
BM
cell
derivatives
on
outcome,
we
generated
chimeric
mice
by
transplanting
from
injured
or
sham
(i.e.,
90
days
post-surgery)
congenic
donor
into
otherwise
healthy,
age-matched,
irradiated
CD45.2
C57BL/6
(WT)
hosts.
Immune
were
evaluated
flow
cytometry,
multiplex
ELISA,
NanoString
technology.
Moderate-to-severe
was
induced
controlled
cortical
measured
using
a
battery
behavioral
tests.
Results
transcriptome
lineage
−
c-Kit
+
Sca1
(LSK+)
mice,
including
modified
epigenetic
senescence
pathways.
After
8
weeks
reconstitution,
peripheral
myeloid
TBI→WT
showed
significantly
higher
oxidative
stress
levels
reduced
phagocytic
activity.
At
eight
months
after
leukopenic,
with
continued
phagocytosis
responses,
as
persistent
deficits.
Gene
expression
analysis
revealed
BM-driven
neuropathology
respectively.
Chimeric
subjected
at
post-reconstitution
longer
reconstitution
periods
time
post-injury)
associated
increased
microgliosis
leukocyte
infiltration.
Pre-treatment
senolytic
agent,
ABT-263,
improved
performance
aged
baseline,
although
it
did
attenuate
acutely
brain.
Conclusions
activation
progressive
dysfunction
pool,
which
drives
long-term
deficits
hematopoiesis,
immunity,
function,
altered
sensitivity
subsequent
injury.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(5), P. 1074 - 1074
Published: May 13, 2024
Parkinson’s
disease
(PD),
a
progressive
neurodegenerative
disease,
has
no
cure,
and
current
therapies
are
not
effective
at
halting
progression.
The
affects
mid-brain
dopaminergic
neurons
and,
subsequently,
the
spinal
cord,
contributing
to
many
debilitating
symptoms
associated
with
PD.
GTP-binding
protein,
Rho,
plays
significant
role
in
cellular
pathology
of
downstream
effector
Rho-associated
kinase
(ROCK),
multiple
functions,
including
microglial
activation
induction
inflammatory
responses.
Activated
microglia
have
been
implicated
diseases,
PD,
that
initiate
responses,
leading
neuron
death.
Calpain
expression
activity
is
increased
following
glial
activation,
which
triggers
Rho-ROCK
pathway
induces
T
cell
migration
as
well
mediates
toxic
α-synuclein
(α-syn)
aggregation
death,
indicating
pivotal
for
calpain
degenerative
processes
Increased
may
represent
new
mechanism
oxidative
damage
aging.
This
review
will
summarize
stress
α-syn
aggregation,
their
influence
on
process
PD
aging,
possible
strategies
research
directions
therapeutic
intervention.
Cell Reports Medicine,
Journal Year:
2024,
Volume and Issue:
5(9), P. 101715 - 101715
Published: Sept. 1, 2024
Progression
of
acute
traumatic
brain
injury
(TBI)
into
chronic
neurodegeneration
is
a
major
health
problem
with
no
protective
treatments.
Here,
we
report
that
acutely
elevated
mitochondrial
fission
after
TBI
in
mice
triggers
persisting
17
months
later,
equivalent
to
many
human
decades.
We
show
increased
mouse
related
levels
1
protein
(Fis1)
and
Fis1
also
TBI.
Pharmacologically
preventing
from
binding
its
partner,
dynamin-related
(Drp1),
for
2
weeks
normalizes
the
balance
fission/fusion
prevents
chronically
impaired
bioenergetics,
oxidative
damage,
microglial
activation
lipid
droplet
formation,
blood-brain
barrier
deterioration,
neurodegeneration,
cognitive
impairment.
Delaying
treatment
until
8
offers
protection.
Thus,
time-sensitive
inhibition
may
represent
strategy
protect
patients
neurodegeneration.
Journal of Neurochemistry,
Journal Year:
2025,
Volume and Issue:
169(1)
Published: Jan. 1, 2025
ABSTRACT
Aging
is
the
most
common
risk
factor
for
Multiple
Sclerosis
(MS)
disease
progression.
Cellular
senescence,
irreversible
state
of
cell
cycle
arrest,
main
driver
aging
and
has
been
found
to
accumulate
prematurely
in
neurodegenerative
diseases,
including
Alzheimer's
Parkinson's
disease.
senescence
central
nervous
system
MS
patients
recently
gained
attention,
with
several
studies
providing
evidence
that
demyelination
induces
cellular
hallmarks
p16INK4A
p21
expression,
oxidative
stress,
senescence‐associated
secreted
factors.
Here
we
discuss
current
animal
models
different
glial
populations
system,
highlighting
major
gaps
field
still
remain.
As
premature
may
exacerbate
inflammation,
resulting
inhibition
myelin
repair,
it
critical
increase
understanding
vivo,
functional
effects
on
cells,
impact
removing
senescent
cells
remyelination
MS.
This
emerging
holds
promise
opening
new
avenues
treatment
patients.
image
ACS Chemical Neuroscience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 7, 2025
Traumatic
brain
injury
(TBI)
is
a
complex
and
multifaceted
condition
that
can
result
in
cognitive
behavioral
impairments.
One
aspect
of
TBI
has
received
increasing
attention
recent
years
the
role
microglia,
brain-resident
immune
cells,
pathophysiology
injury.
Specifically,
evidence
suggests
dysfunction
microglial
autophagy,
process
by
which
cells
degrade
recycle
their
own
damaged
components,
may
contribute
to
development
progression
TBI-related
Here,
we
unravel
pathways
microglia
autophagic
dysregulation
predisposes
secondary
damage
neurological
deficits
following
TBI.
An
overview
perpetuation
worsening
inflammatory
response,
neuroinflammation,
neuronal
cell
death
follows.
Further,
have
evaluated
several
signaling
processes
autophagy
dysfunction-mediated
inflammation,
neurodegeneration,
poor
outcome
Additionally,
discussion
on
small
molecule
therapeutics
employed
modulate
these
mechanisms
treat
been
presented.
However,
additional
research
required
fully
understand
behind
underlying
uncover
potential
therapeutic
targets
for
restoring
failure
Journal of Biophotonics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 20, 2025
Immunophenotyping
provides
valuable
prognostic
and
diagnostic
information,
but
is
technically
complex
expensive.
The
assessment
of
autofluorescence
label-free
information
on
cell
identity.
However,
research
its
application
to
immunophenotyping
has
been
heterogenous.
This
systematic
review
was
carried
out
identify
synthesise
all
available
evidence
the
use
for
immunophenotyping.
Eighty
three
full
texts
were
included.
There
a
focus
neutrophils
(20
papers)
macrophages
(22
with
alveolar
(13
forming
subcategory.
Seven
studies
investigated
monocytes,
focused
microglia,
two
dendritic
cells,
five
mast
nine
granulocytes,
thirteen
eosinophils,
one
erythrophagocytic
natural
killer
cells.
Eleven
uncategorised
immune
populations.
Translation
findings
into
clinical
requires
reproducible
methods,
along
clear
reporting
excitation
emission
parameters,
greater
primary
samples.
Drug Delivery,
Journal Year:
2025,
Volume and Issue:
32(1)
Published: April 15, 2025
The
dysregulation
of
blood-brain
barrier
(BBB)
activates
pathological
mechanisms
such
as
neuroinflammation
after
traumatic
brain
injury
(TBI),
and
glymphatic
system
dysfunction
accelerates
toxic
waste
accumulation
TBI.
It
is
essential
to
find
an
effective
way
inhibit
inflammation
repair
BBB
TBI;
however,
lasting
drug
therapy
remains
challenging
because
severely
prevents
drugs
from
being
delivered
central
nervous
system.
Transferrin
receptors
(TfRs)
are
mainly
expressed
on
capillary
endothelial
cells.
Here,
we
report
a
TfR-targeted
nanomedicine
for
TBI
treatment
by
penetrating
delivering
fluvoxamine
(Flv).
polypeptide
liposome
loaded
with
Flv
(TPL-Flv)
implements
cell
targeting
ability
human
umbilical
vein
cells
(HUVECs)
in
vitro
detected
flow
cytometry,
safety
was
proved
through
viability
analysis
blood
routine
biochemistry
analysis.
Afterwards,
established
controlled
cortical
impact
model
explore
TPL-Flv
administration
effects
mice.
We
confirmed
that
could
stimulate
CXCR4/SDF-1
signaling
pathway,
activate
Treg
cells,
also
alleviated
disruption
restored
aquaporin-4
(AQP4)
polarization,
well
reversed
dysfunction.
Furthermore,
accomplished
remarkable
improvement
motor
cognitive
functions.
These
findings
demonstrate
can
effectively
cross
achieve
delivery
cerebral
tissue,
validating
its
potential
improve
therapeutic
outcomes
Neurology International,
Journal Year:
2025,
Volume and Issue:
17(4), P. 57 - 57
Published: April 16, 2025
Background:
Severe
spinal
cord
injury
(SCI)
represents
a
debilitating
condition
with
long-term
physical
and
socioeconomic
impacts.
Understanding
the
pathophysiology
of
SCI
therapeutic
interventions
such
as
decompressive
laminectomy
expansive
duraplasty
is
crucial
for
optimizing
patient
outcomes.
Objective:
This
systematic
review
explores
evaluates
evidence
linking
to
improved
neuroplasticity
recovery.
Methods:
A
comprehensive
search
was
conducted
in
PubMed,
Web
Science,
Cochrane
Library
studies
on
surgery
SCI.
Inclusion
criteria
were
original
articles
investigating
pathophysiology,
mechanisms,
or
surgical
Data
pathophysiological
changes,
molecular
markers,
functional
outcomes
extracted.
Results:
From
1240
initial
articles,
43
included,
encompassing
both
animal
models
human
clinical
data.
Findings
highlighted
role
inflammatory
cascades,
blood–spinal
barrier
disruption,
neurotrophic
factor
modulation
Decompressive
associated
intrathecal
pressure
(ITP)
management
BDNF
GAP-43.
Conclusions:
underscores
potential
While
suggests
benefits
promoting
neuroplasticity,
further
research
needed
elucidate
mechanisms
refine
interventions.